Skip to main content
Top
Published in: Reactions Weekly 1/2008

01-10-2008 | Case report

Urapidil

Hypotension in an elderly patient during alteplase thrombolysis: case report

Published in: Reactions Weekly | Issue 1/2008

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Bugnicourt J-M, Duru C, Picard C, Godefroy O.Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke. Clinical Therapeutics 30: 1675-1680, No. 9, Sep 2008 - France Bugnicourt J-M, Duru C, Picard C, Godefroy O.Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke. Clinical Therapeutics 30: 1675-1680, No. 9, Sep 2008 - France
Metadata
Title
Urapidil
Hypotension in an elderly patient during alteplase thrombolysis: case report
Publication date
01-10-2008
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2008
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-200812240-00076

Other articles of this Issue 1/2008

Reactions Weekly 1/2008 Go to the issue

Case report

Fluconazole

Case report

Amisulpride

Case report

Nitrous oxide

Case report

Haloperidol

Case report

Sunitinib

Case report

Olanzapine